(Q35743279)

10 August 2017

1 reference

title

Approaches to enhance the efficacy of DNA vaccines (English)

1 reference

10 August 2017

2

Lorne A Babiuk

1 reference

PubMed ID

15077722

Sylvia van Drunen Littel-van den Hurk

10 August 2017

series ordinal

3

object named as

Sylvia van Drunen Littel-van den Hurk

1 reference

10 August 2017

1

Sharmila Manoj

1 reference

PubMed ID

15077722

10 August 2017

language of work or name

1 reference

1 January 2004

1 reference

Critical Reviews in Clinical Laboratory Sciences

10 August 2017

1 reference

10 August 2017

41

1 reference

10 August 2017

1

1 reference

10 August 2017

1-39

1 reference

Direct gene transfer into mouse muscle in vivo

10 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Induction of immune responses to bovine herpesvirus type 1 gD in passively immune mice after immunization with a DNA-based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Immunization of non-human primates with DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Intracellular barriers to non-viral gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Endosomes, lysosomes: their implication in gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Genetic immunization: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

The antiviral effects of the interferons and their inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Regulation of transgene expression in genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Gene therapy: designer promoters for tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Generation of a synthetic mammalian promoter library by modification of sequences spacing transcription factor binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Differential codon usage: a safeguard against inappropriate expression of specialized genes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Codon bias and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Codon usage and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Codon usages in different gene classes of the Escherichia coli genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Evolution of base composition and codon usage bias in the genus Flavivirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Differences in codon usage among genes encoding proteins of different function in Rhodobacter capsulatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Polyvalent DNA vaccines with bidirectional promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Size and topology of exogenous DNA as determinant factors of transgene transcription in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Functional cooperation between T helper cell determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Applications of DNA shuffling to pharmaceuticals and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A family of compact plasmid vectors for DNA immunization in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Recombinant protein production with minimal-antibiotic-resistance vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Repressor titration: a novel system for selection and stable maintenance of recombinant plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Minimizing side effects of ballistic gene transfer into the murine corneal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Influence of ballistic gene transfer on antigen-presenting cells in murine corneas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Innate immunity: the virtues of a nonclonal system of recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Toll-like receptors: a family of pattern-recognition receptors in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Therapeutic perspectives of in vivo cell electropermeabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Efficient nonviral cutaneous transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Protection against influenza virus challenge by topical application of influenza DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Targeting the mucosa: genetically engineered vaccines and mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Intralymphatic immunization enhances DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A role for liposomes in genetic vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Genetic immunization using nanoparticles engineered from microemulsion precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Coating of cationized protein on engineered nanoparticles results in enhanced immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Topical immunization using nanoengineered genetic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Induction of mucosal immune responses following enteric immunization with antigen delivered in alginate microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Virus-assisted loading of polymer nanocontainer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhanced reporter gene expression in cells transfected in the presence of DMI-2, an acid nuclease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Exploitation of mammalian host cell functions by bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Secretion of different listeriolysin cognates by recombinant attenuated Salmonella typhimurium: superior efficacy of haemolytic over non-haemolytic constructs after oral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Recent advances with recombinant bacterial vaccine vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Delivery of protein antigens and DNA by attenuated intracellular bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Prothymosin alpha enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Transgene as vaccine for chlamydia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Advances in the development of non-human viral DNA-vectors for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Single amino acid substitutions in gD of herpes simplex virus 1 confer resistance to gD-mediated interference and cause cell-type-dependent alterations in infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

The role of complement in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

C3d enhancement of neutralizing antibodies to measles hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Structural characteristics of CD40 ligand that determine biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Hijacking a chaperone: manipulation of the MHC class II presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhancing T cell activation and antiviral protection by introducing the HIV-1 protein transduction domain into a DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Intercellular delivery of functional p53 by the herpesvirus protein VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Intercellular trafficking and protein delivery by a herpesvirus structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A genetic immunization adjuvant system based on BVP22-antigen fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Regulation of the immune response by antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

T cells compete for access to antigen-bearing antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Genetic adjuvants for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

The effect of interferon-gamma on genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

IL-6 induces long-term protective immunity against a lethal challenge of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

T cell affinity maturation by selective expansion during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A role for the disintegrin domain of cyritestin, a sperm surface protein belonging to the ADAM family, in mouse sperm-egg plasma membrane adhesion and fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Sperm adhesion molecules: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Protection against mycoplasma infection using expression-library immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Mammalian artificial chromosomes as vectors: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Strategies for engineering human chromosomes with therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

'Troy-bodies': antibodies as vector proteins for T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Vaccination of pigs with a recombinant porcine adenovirus expressing the gD gene from pseudorabies virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Humoral and cellular immune responses to HIV-1 Nef in mice DNA-immunised with non-replicating or self-replicating expression vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360490269251

10.1080/10408360490269251

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15077722